home / stock / tcon / tcon news

TCON News and Press, TRACON Pharmaceuticals Inc. From 06/16/23

Stock Information
Company Name: TRACON Pharmaceuticals Inc.
Stock Symbol: TCON
Market: OTC
Website: traconpharma.com
Menu
TCON TCON Quote TCON Short TCON News TCON Articles TCON Message Board
Get TCON Alerts

News, Short Squeeze, Breakout and More Instantly...
TCON - TRACON Pharmaceuticals to Present at the Maxim Group Healthcare Virtual Conference

SAN DIEGO, June 16, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform ...
TCON - TRACON Pharmaceuticals Announces Enforcement Action to Collect Binding Arbitration Award from I-Mab Biopharma

SAN DIEGO, June 15, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform ...

TCON - TRACON Pharmaceuticals Announces Poster Presentations for Envafolimab and TRC102 at the 2023 ASCO Annual Meeting

SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform to part...

TCON - TRACON Pharmaceuticals, Inc. (TCON) Q1 2023 Earnings Call Transcript

2023-05-10 22:18:09 ET TRACON Pharmaceuticals, Inc. (TCON) Q1 2023 Earnings Conference Call May 10, 2023, 04:30 PM ET Company Participants Charles Theuer - CEO, President & Director Scott Brown - CFO Conference Call Participants Edward White - H.C. Wa...
TCON - Tracon GAAP EPS of -$0.36 misses by $0.09

2023-05-10 16:50:18 ET Tracon press release ( NASDAQ: TCON ): Q1 GAAP EPS of -$0.36 misses by $0.09 . Cash and cash equivalents were $6.6 million at March 31, 2023, compared to $17.4 million at December 31, 2022, Net loss for the first quarter of 2023 was $8.5 mill...

TCON - TRACON Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

SAN DIEGO, May 10, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life...

TCON - TRACON to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 10, 2023

SAN DIEGO, May 03, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life...
TCON - ML and LGMK among mid-day movers

2023-04-25 13:30:38 ET Gainers: CXApp ( CXAI ) +82% . Petros Pharmaceuticals ( PTPI ) +49% . LogicMark ( LGMK ) +28% . Apollomics ( APLM ) +23% . The Aaron's Company ( AAN ) +18% . Baudax Bio ( BXRX ) +18% . Predi...

TCON - Baudax, Petros top healthcare gainers; Tracon, Maia among losers

2023-04-25 10:06:07 ET Gainers: Baudax Bio ( BXRX ) +48% . Petros Pharmaceuticals ( PTPI ) +48% . Morphic Holding ( MORF ) +22% . Arrowhead Pharmaceuticals ( ARWR ) +17% . Medpace Holdings ( MEDP ) +17% . Losers: Trac...

TCON - EC, SES and DAWN among pre-market losers

2023-04-25 09:04:56 ET TRACON Pharmaceuticals ( TCON ) -51% after I-Mab gets favorable ruling in arbitration. Appreciate Holdings ( SFR ) -26% . First Republic Bank ( FRC ) -22% after Q1 earning release . Netcapital ( NCPL ) -22% . T...
Previous 10 Next 10